World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
100
Citations
32550
World Ranking
8340
National Ranking
4309

Research.com Recognitions

  • 2002 - Fellow of the American Association for the Advancement of Science (AAAS)

Overview

Richard F. Ambinder is affiliated with Johns Hopkins University in the United States. Their scientific work mainly focuses on the field of Medicine, with significant contributions to Oncology, Pathology and Forensic Medicine, Hematology, Immunology, and Epidemiology.

Their research topics include the following:

  • Lymphoma Diagnosis and Treatment
  • Viral-associated cancers and disorders
  • Hematopoietic Stem Cell Transplantation
  • Acute Lymphoblastic Leukemia research
  • Immune Cell Function and Interaction
  • Polyomavirus and related diseases
  • HIV Research and Treatment

Frequent co-authors collaborating with Richard F. Ambinder include:

  • Javier Bolaños-Meade
  • Nina D. Wagner-Johnston
  • Richard J. Jones
  • Ephraim J. Fuchs
  • Lode J. Swinnen

The scientist has published extensively in certain venues with notable frequency, including:

  • Blood
  • Transplantation and Cellular Therapy
  • Journal of Clinical Oncology
  • Blood Advances
  • Biology of Blood and Marrow Transplantation

Some of the recent papers by Richard F. Ambinder are:

  • National Marrow Donor Program-Sponsored Multicenter, Phase II Trial of HLA-Mismatched Unrelated Donor Bone Marrow Transplantation Using Post-Transplant Cyclophosphamide, 2021, Journal of Clinical Oncology
  • Hodgkin Lymphoma, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology, 2020, Journal of the National Comprehensive Cancer Network
  • Haploidentical BMT for severe aplastic anemia with intensive GVHD prophylaxis including posttransplant cyclophosphamide, 2020, Blood Advances
  • Ipilimumab, nivolumab, and brentuximab vedotin combination therapies in patients with relapsed or refractory Hodgkin lymphoma: phase 1 results of an open-label, multicentre, phase 1/2 trial, 2020, The Lancet Haematology
  • Single-cell transcriptional landscapes reveal HIV-1-driven aberrant host gene transcription as a potential therapeutic target, 2020, Science Translational Medicine

In 2002, Richard F. Ambinder was recognized as a Fellow of the American Association for the Advancement of Science (AAAS).

Best Publications

  • HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide

    Leo Luznik;Paul V. O'Donnell;Paul V. O'Donnell;Heather J. Symons;Allen R. Chen

  • Clonogenic Multiple Myeloma Progenitors, Stem Cell Properties, and Drug Resistance

    William Matsui;Qiuju Wang;James P. Barber;Sarah Brennan

  • Epstein-Barr virus in AIDS-related primary central nervous system lymphoma

    E. MacMahon;P. Charache;D. Glass;R.B. Mann

  • Epstein‐Barr virus‐associated Hodgkin's disease: Epidemiologic characteristics in international data

    Sally L. Glaser;Ruby J. Lin;Susan L. Stewart;Richard F. Ambinder

  • Rituximab does not improve clinical outcome in a randomized phase 3 trial of CHOP with or without rituximab in patients with HIV-associated non-Hodgkin lymphoma: AIDS-Malignancies Consortium Trial 010

    Lawrence D. Kaplan;Jeannette Y. Lee;Richard F. Ambinder;Joseph A. Sparano

  • Autologous Bone Marrow Transplantation in Patients with Acute Nonlymphocytic Leukemia, Using ex Vivo Marrow Treatment with 4-Hydroperoxycyclophosphamide

    Andrew M. Yeager;Herbert Kaizer;George W. Santos;Rein Saral

  • Acyclovir Halts Progression of Herpes Zoster in Immunocompromised Patients

    Balfour Hh;Bean B;Laskin Ol;Ambinder Rf

  • High-dose cyclophosphamide as single-agent, short-course prophylaxis of graft-versus-host disease.

    Leo Luznik;Javier Bolaños-Meade;Marianna Zahurak;Allen R. Chen

  • Evidence of a graft-versus-lymphoma effect associated with allogeneic bone marrow transplantation.

    Richard J. Jones;Richard F. Ambinder;Steven Piantadosi;George W. Santos

  • Hodgkin lymphoma: A review and update on recent progress.

    Satish Shanbhag;Richard F. Ambinder

  • Association of BK virus with failure of prophylaxis against hemorrhagic cystitis following bone marrow transplantation.

    Atul Bedi;Carole B. Miller;Janet L. Hanson;Steven Goodman

  • Comparison of Outcomes of HLA-Matched Related, Unrelated, or HLA-Haploidentical Related Hematopoietic Cell Transplantation following Nonmyeloablative Conditioning for Relapsed or Refractory Hodgkin Lymphoma

    Lauri M. Burroughs;Paul V. O'Donnell;Brenda M. Sandmaier;Barry E. Storer

  • Detection of EBV gene expression in Reed-Sternberg cells of Hodgkin's disease

    Tzyy Choou Wu;R. B. Mann;P. Charache;S. D. Hayward

  • Chemotherapy for Human Immunodeficiency Virus–Associated Non-Hodgkin’s Lymphoma in Combination With Highly Active Antiretroviral Therapy

    Lee Ratner;Jeannette Lee;Shenghui Tang;David Redden

  • Risk-stratified outcomes of nonmyeloablative, HLA-haploidentical BMT with high-dose posttransplantation cyclophosphamide

    Shannon R. McCurdy;Jennifer A. Kanakry;Margaret M. Showel;Hua Ling Tsai

  • Nonmyeloablative HLA-Haploidentical Bone Marrow Transplantation with High-Dose Posttransplantation Cyclophosphamide: Effect of HLA Disparity on Outcome

    Yvette L. Kasamon;Leo Luznik;Mary S. Leffell;Jeanne Kowalski

  • Comparison of Genetic Variability at Multiple Loci across the Genomes of the Major Subtypes of Kaposi’s Sarcoma-Associated Herpesvirus Reveals Evidence for Recombination and for Two Distinct Types of Open Reading Frame K15 Alleles at the Right-Hand End

    Lynn J. Poole;Jian Chao Zong;Dolores M. Ciufo;Donald J. Alcendor

  • Rituximab plus concurrent infusional EPOCH chemotherapy is highly effective in HIV-associated B-cell non-Hodgkin lymphoma.

    Joseph A. Sparano;Jeannette Y. Lee;Lawrence D. Kaplan;Alexandra M. Levine

  • Functional domains of Epstein-Barr virus nuclear antigen EBNA-1.

    R F Ambinder;M A Mullen;Y N Chang;G S Hayward

  • NCCN guidelines ® insights hodgkin lymphoma, version 1.2018 featured updates to the NCCN guidelines

    Richard T. Hoppe;Ranjana H. Advani;Weiyun Z. Ai;Richard F. Ambinder

Frequent Co-Authors

Richard J. Jones
Richard J. Jones Johns Hopkins University
Leo Luznik
Leo Luznik Johns Hopkins University
Ephraim J. Fuchs
Ephraim J. Fuchs Johns Hopkins University
Qian Tao
Qian Tao Chinese University of Hong Kong
Jeannette Y. Lee
Jeannette Y. Lee University of Arkansas for Medical Sciences
Michael J. Borowitz
Michael J. Borowitz Johns Hopkins University
Gary S. Hayward
Gary S. Hayward Johns Hopkins University
Marianna Zahurak
Marianna Zahurak Johns Hopkins University
Otoniel Martínez-Maza
Otoniel Martínez-Maza University of California, Los Angeles
Lee Ratner
Lee Ratner Washington University in St. Louis

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a traditional medical degree in the U.S. is a significant commitment, but there are many online degrees and career pathways worth considering in the rapidly expanding healthcare field.

For those interested in pharmacy, the 3-year online pharmd provides a flexible and accelerated route to becoming a licensed pharmacist, allowing professionals to balance their studies with existing commitments.

Those curious about the administrative side of healthcare can explore the bachelor of health information management online. This degree opens doors to roles in hospital information systems, data security, and healthcare administration.

If you’re seeking a quick entry into the healthcare workforce, there are many cheapest medical billing and coding online courses that provide foundational training for essential behind-the-scenes jobs in clinics and hospitals.

For nurses wanting to elevate their careers, the cheapest online acute care nurse practitioner programs offer advanced clinical skills and credentials, often with the flexibility of online learning.

Each of these online options offers streamlined and cost-effective opportunities to advance or begin your career in healthcare—making them excellent alternatives or complements to traditional medical studies.

Best Scientists Citing Richard F. Ambinder

Trending Scientists